Medical abortion care encompasses the management of various clinical conditions including spontaneous and induced abortion (both viable and non-viable pregnancies), incomplete abortion and intrauterine fetal demise, as well as post-abortion contraception. Medical management of abortion generally involves...
Abortion, Incomplete/therapy,
Fetal Death,
Abortion, Induced/methods,
Mifepristone/administration & dosage,
Pregnancy Trimesters,
Abortion, Induced/rehabilitation,
Misoprostol/administration & dosage,
Abortifacient Agents, Nonsteroidal/administration & dosage,
Drug Therapy, Combination
DESCRIPTION: The Joint Task Force on Practice Parameters, which comprises representatives of the American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI), formed a workgroup to review evidence and provide guidance to health care provide...
Adrenal Cortex Hormones,
Histamine Antagonists,
Leukotriene Antagonists,
Administration, Intranasal,
Administration, Oral,
Age Factors,
Drug Therapy, Combination,
Histamine Antagonists/therapeutic use,
Leukotriene Antagonists/therapeutic use,
Rhinitis, Allergic, Seasonal,
Adrenal Cortex Hormones/administration & dosage,
Adrenal Cortex Hormones/therapeutic use,
Rhinitis, Allergic, Seasonal/diagnosis,
Rhinitis, Allergic, Seasonal/drug therapy
Jones, N. L;
Koletzko, S;
Goodman, K;
Bontems, P;
Cadranel, S;
Casswall, T;
Czinn, S;
Gold, B. D;
Guarner, J;
Elitsur, Y;
Homan, M;
Kalach, N;
Kori, M;
Madrazo, A;
Megraud, F;
Papadopoulou, A;
Rowland, M.
BACKGROUND: Because of the changing epidemiology of Helicobacter pylori infection and low efficacy of currently recommended therapies, an update of the European Society for Paediatric Gastroenterology Hepatology and Nutrition/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition...
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on oral pharmacologic treatment of type 2 diabetes in adults. This guideline serves as an update to the 2012 ACP guideline on the same topic. This guideline is endor...
Diabetes Mellitus, Type 2/drug therapy,
Arterial Pressure/drug effects,
Diabetic Angiopathies/prevention & control,
Glycated Hemoglobin,
Heart Rate/drug effects,
Hypoglycemic Agents/administration & dosage,
Metformin/administration & dosage,
Sulfonylurea Receptors/administration & dosage,
Weight Loss,
Drug Therapy, Combination
Ofrecer recomendaciones basadas en la evidencia para la prevención, detección, tratamiento y seguimiento de las queratosis actínicas, con el fin de apoyar al personal de salud en los diferentes niveles de atención, buscando garantizar una atención integral, homogénea, con calidad, equidad y eficien...
Leukemia, Lymphoid/diagnosis,
Leukemia, Lymphoid/therapy,
Leukemia, Myeloid/diagnosis,
Leukemia, Myeloid/therapy,
Cytogenetic Analysis/methods,
Vincristine/therapeutic use,
Doxorubicin/therapeutic use,
Dexamethasone/therapeutic use,
Imatinib Mesylate/therapeutic use,
Dasatinib/therapeutic use,
Antibodies, Monoclonal/therapeutic use,
Drug Therapy, Combination,
Transplantation, Homologous
Gisbert, JP;
Molina-Infante, J;
Amador, J;
Bermejo, F;
Bujanda, L;
Calvet, X;
Castro-Fernández, M;
Cuadrado-Lavín, A;
Elizalde, JI;
Gene, E;
Gomollón, F;
Lanas, Á;
Martín de Argila, C;
Mearin, F;
Montoro, M;
Pérez-Aisa, Á;
Pérez-Trallero, E;
McNicholl, AG.
Helicobacter pylori approximately infect 50% of Spanish population and causes chronic gastritis, peptic ulcer and gastric cancer. Until now, three consensus meetings on H.pylori infection had been performed in Spain (the last in 2012). The changes in the treatment schemes, and the increasing available ev...
Anti-Bacterial Agents/therapeutic use,
Proton Pump Inhibitors/therapeutic use,
Bismuth/therapeutic use,
Algorithms,
Delphi Technique,
Drug Therapy, Combination,
Gastritis/complications,
Helicobacter Infections,
Helicobacter pylori,
Probiotics,
Proton Pump Inhibitors,
Recurrence,
Salvage Therapy,
Stomach Neoplasms,
Stomach Ulcer,
Treatment Failure,
Gastritis/drug therapy,
Helicobacter Infections/drug therapy,
Helicobacter pylori/drug effects
Macle, L;
Cairns, J;
Leblanc, K;
Tsang, T;
Skanes, A;
Cox, JL;
Healey, JS;
Bell, A;
Pilote, L;
Andrade, JG;
Mitchell, LB;
Atzema, C;
Gladstone, D;
Sharma, M;
Verma, S;
Connolly, S;
Dorian, P;
Parkash, R;
Talajic, M;
Nattel, S;
Verma, A.
The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic therapy for AF pa...
Anticoagulants,
Cardiotonic Agents,
Platelet Aggregation Inhibitors,
Digoxin,
Magnesium,
Acute Coronary Syndrome/therapy,
Algorithms,
Anticoagulants/therapeutic use,
Atrial Appendage/surgery,
Atrial Fibrillation,
Cardiac Pacing, Artificial,
Cardiotonic Agents/adverse effects,
Catheter Ablation,
Cardiotonic Agents/administration & dosage,
Atrial Fibrillation/therapy,
Atrial Fibrillation/complications,
Hemorrhage/chemically induced,
Hemorrhage/prevention & control,
Magnesium/therapeutic use,
Percutaneous Coronary Intervention,
Platelet Aggregation Inhibitors/therapeutic use,
Postoperative Complications/prevention & control,
ST Elevation Myocardial Infarction/therapy,
Stroke/prevention & control,
Coronary Artery Disease/complications,
Digoxin/administration & dosage,
Digoxin/adverse effects,
Drug Therapy, Combination,
Factor Xa Inhibitors/therapeutic use,
Fibrinolytic Agents/therapeutic use,
Factor Xa Inhibitors
Singh, J. A;
Saag, K. G;
Bridges Junior, S. L;
Akl, E. A;
Bannuru, R. R;
Sullivan, M. C;
Vaysbrot, E;
McNaughton, C;
Osani, M;
Shmerling, R. H;
Curtis, J. R;
Furst, D. E;
Parks, D;
Kavanaugh, A;
O'Dell, J;
King, C;
Leong, A;
Matteson, E. L;
Schousboe, J. T;
Drevlow, B;
Ginsberg, S;
Grober, J;
St Clair, E. W;
Tindall, E;
Miller, A. S;
McAlindon, T.
OBJECTIVE: To develop a new evidence-based, pharmacologic treatment guideline for rheumatoid arthritis (RA). METHODS: We conducted systematic reviews to synthesize the evidence for the benefits and harms of various treatment options. We used the Grading of Recommendations Assessment, Development and Eval...
Rationale for the guidelines: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. These guidelines provide updated trea...
Rationale for the guidelines: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. There is an urgent need to update tre...
Neisseria gonorrhoeae,
Gonorrhea/drug therapy,
Drug Resistance, Microbial,
Cefixime/administration & dosage,
Spectinomycin/administration & dosage,
Ceftriaxone/administration & dosage,
Gentamicins/administration & dosage,
Kanamycin/administration & dosage,
Tetracycline/administration & dosage,
Erythromycin/administration & dosage,
Povidone-Iodine/administration & dosage,
Silver Nitrate/administration & dosage,
Chloramphenicol/therapeutic use,
Anti-Bacterial Agents/administration & dosage,
Drug Therapy, Combination
